Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
1 September 2019 (17:15 - 17:32)
Organised by:
About the speaker
University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Professor B. Rocca (Casamassima, IT)
Assistant Professor C. Koh (Singapore, SG)
Professor L. Jennings (Memphis, US)
Access the full session
The Event
ESC Congress 2019
1 September 2019
17:15 CET
